Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for neuroprotection in preterm infants
IRCT20120826010664N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of magnesium sulfate in preterm birth (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Neonatal neuromotor development. Started Dec 2019; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
preterm birth
Beyond the preview
Go deeper on IRCT20120826010664N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120826010664N5.